To present the 2025 revision of the Japan Society of Gynecologic Oncology Clinical Practice Guidelines for the treatment of ovarian, fallopian tube, and primary peritoneal cancers, which incorporates recent advances in surgical strategies, molecular diagnostics, and maintenance therapies within the context of the Japan...
T. Shoji, Tsukasa Baba, Yoichi Kobayashi et al.· Journal of Gynecologic Oncol...· 1 citation
OBJECTIVE
Human epidermal growth factor receptor (HER) 3, encoded by the ERBB3 gene, transduces signals most effectively when dimerized with HER2. Although HER3 protein expression has been considered a poor prognostic factor in ovarian cancer, limited data exist on changes in HER3 protein expression and ERBB3 messenger...
K. Yokosu, Riu Yamashita, Satoshi Fujii et al.· Journal of Gynecologic Oncol...· 0 citations
Endometrial cancer (EC) is one of the most prevalent gynecological malignancies. EC is characterized by limited therapeutic options and a substantial unmet medical need, particularly in advanced or metastatic stages. Although a high prevalence of concurrent
PIK3CA
and
CTNNB1
mutations has been reported in patie...
Takehiro Nakao, R. Kamata, Hitoshi Saito et al.· Cell Death Discovery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.